No profile data available.
Kardigan, Inc. (KARD) is a listed company, based in Princeton, United States, with about 241 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$191.94 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $1.37 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure.
Kardigan reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$1.37 billion as of October 9, 2026.